Hip Replacement Implant Recall Lawsuit Attorney Hip Implant Side Effects

Hip Replacement Implant Recall Lawsuit Attorney Hip Implant Side Effects

Hip Replacement Implant Recall Information

Everything You Need To Know About Defective Hip Replacement Implant Recalls ... If you HAVE Questions About Any Information Here, Please Contact Us.

The FDA has received more than 17,000 complaints highlighting large-scale failure and side effects of hip implants in the last one decade. The metal particles released by these artificial hip implants have been blamed for cardiovascular, thyroid, metal poisoning, and nervous system problems, while their failure in less than expected time and fracture rates necessitated patients to undergo revision or secondary surgeries. In May 2011, the FDA called for complete assessment of safety concerns associated with metal hip implant systems and components of 21 manufacturers. Recalls over all these years prompted by regulator warnings and revelations of independent studies have led to filing of thousands of hip implant lawsuits claiming product liability against manufacturers. A Forbes report published in December 2011 estimated that the total number of hip implant lawsuits would cross 30,000, costing the industry $5 billion in settlements.

DePuy ASR Hip Replacement Implant Recall

Read more: Hip Replacement Implant Recall Lawsuit Attorney Hip Implant Side Effects

Merck Coppertone Class Action Lawsuit Settlement

Merck Coppertone Class Action Lawsuit Settlement

Merck Class Action Lawsuit Settlement

New Jersey-based pharmaceutical major Merck & Co had agreed to settle the Coppertone class action lawsuit that was filed nine years ago. According to reports, the total compensation is expected to be between $3 million and $10 million, with each plaintiff expected to get up to $1.50 million for each Coppertone product purchased. The settlement agreed on September 21, 2012 also forbids Merck from using specific words, such as waterproof, all day protection, sweat proof, and sunblock in product labels, advertisements, and marketing material promoting Coppertone sunscreens in the United States.

What is The Merck Coppertone Class Action Lawsuit

Coppertone sunscreen lotion was originally owned by Schering-Plough, the manufacturer of foot care brand Dr Scholls and other pharmaceutical drugs. The suntan lotion brand came under increasing scrutiny in 2002 for its labeling and advertisement claims. Beginning October 2003, a number of lawsuits, including a class action, were filed in different US courts, claiming exaggerated labeling of Coppertone products. The plaintiffs had alleged that the manufacturer overstated the strength of Coppertone sunscreens in its advertising and promotion campaigns.

Merck acquired Schering-Plough in November 2009 for $41 billion and became party to these lawsuits by default, seeking compensation for publicizing false product information. A spokesperson representing Merck has refuted wrongdoing allegations and consequent liability and defended the quality of products as compatible with the latest FDA standards on sun protection lotions. The settlement is "solely for the purpose of avoiding the burden, expense, risk and uncertainty of continuing litigation," according to the agreement details filed by Merck in a New Jersey federal court.

Other Merck Lawsuits And Merck Class Action Lawsuits

The Coppertone class action is one of the many lawsuits filed against Merck for prescription drug side effects, misbranding, wrong marketing practices, and illegal payments to health care professionals. The following are details of various Merck lawsuits and settlements.

Merck Vioxx Lawsuit

Merck has been subject to 25,000 individual, one anti-trust, and 160 class action lawsuits by US residents affected by Vioxx side effects. The arthritis drug was recalled in 2004 after the FDA adverse reporting system confirmed as many as 139,000 heart attacks linked to it in the last one decade of its sale. It was also responsible for causing heart attacks, hypertension, cardiovascular thromboembolic, hepatic insufficiency, ocular side effects, and dermatologic reactions. In July 2008, Merck set aside a fund of $4.85 billion to cover all compensation claims and legal expenses arising out of Vioxx lawsuits.

In August 2005, the first Vioxx lawsuit trial resulted in $20 million compensation to the family of a Texas man. A Rio Grande City court awarded $32 million, including $25 million in punitive damages against Merck, to family of a 71-year-old man, who died of the drug side effects. Merck paid $58 million to 30 state governments to settle anti-trust lawsuits that blamed the defendant of following deceptive market practices and providing misleading information on Vioxx side effects.

Merck Fosamax Lawsuit

More than 2,000 Fosamax lawsuits have been filed against Merck in the United States. Plaintiffs suffered from a number of side effects from the osteoporosis drug, such as jaw necrosis, knee problems, and hip and femur fractures. According to the American Society of Clinical Oncology, Fosamax puts users at a six-time greater risk of esophagus cancer. The plaintiffs have sought compensation from Merck on the ground that it failed to disclose safety information regarding Fosamax side effects and to warn consumers adequately. All federal Fosamax lawsuits have been consolidated at the Southern District of New York. In June 2010, a New York City court awarded $8 million to a plaintiff who suffered from jaw necrosis due to Fosamax side effects.

Merck Propecia Lawsuit

A class action and hundreds of individual lawsuits have been filed against Merck following discovery of Propecia side effects in early 2011. The drug prescribed to contain male hair loss is blamed for causing erectile dysfunction, behavior change, mental impairment, and diminished quality of life. The Propecia lawsuit plaintiffs have alleged that Merck did not mention the side effects on the drug label in the United States despite such warnings by European regulators and consequent label changes in 2008.

Merck NuvaRing Lawsuit

Merck is facing close to 1,000 personal injury and wrongful death claims linked to its popular contraceptive vaginal ring NuvaRing. The device, according to a study published in the British Medical Journal, leads to deep vein thrombosis and other cardiovascular diseases, causing death and disability in many users. Most of the federal NuvaRing lawsuits consolidated under the Eastern District of Missouri have alleged that Merck downplayed the threat of side effects during its drug promotion campaign and did not warn users about the risk disclosed by European public health regulators.

Merck Zocor Lawsuit

On June 1, 2012, a Zocor class action lawsuit filed against Merck in the Eastern District of Louisiana alleged that the manufacturer marketed the drug without warning users about risks associated with it. The serious side effects of the cholesterol-lowering drug include rhabdomyolysis, muscle injuries, and renal impairment. About half-a-dozen individual lawsuits filed in various state courts have also alleged that Merck sold Zocor without warnings despite being aware that it is dangerous to human health.

Merck Vytorin Lawsuit

In August 2009, Merck reached an agreement to pay a compensation of $41.5 million to settle Zetia and Vytroin class action lawsuits. The plaintiffs sued the pharmaceutical company after data released by the manufacturer in January 2008 highlighted that the costly cholesterol-fighting drugs did not offer any extra benefits as claimed by Merck. In March 2012, Merck paid $5.1 million to settle another lawsuit filed over delayed released of the study.

Merck Mumps Vaccine Lawsuit

A Mumps Vaccine class action lawsuit filed against Merck on June 25, 2012 claims that the drug manufacturer misled users on the efficacy of its product. The lawsuit filed by Chatom Primary Care of Alabama claims that the vaccine is "far less effective" than advertised and Merck sold drugs with "questionable efficacy.” The claim is based on the accusations of two Merck virologists, who claimed to have witnessed improper testing and data falsification during the testing process.

Antibiotics Side Effects Lawsuit

Antibiotics Side Effects Lawsuit

Antibiotics Side Effects and Health Problems

Antibiotics, often considered the most potent life savers, can lead to serious side effects. According to a study published in the April issue of The Journal of the American Medical Association, antibiotics, such as fluoroquinolones, pose a severe risk of a retinal detachment among current users of the drug, which could lead to vision loss, blindness, and other visionary problems. Another unpublished study warns of a significantly higher risk of acute kidney failure among the users of fluoroquinolone antiobiotics, which include Cipro, Avelox, and Levaquin.

Levaquin, Cipron, and other antibiotics are known to be toxic to the connective tissue and can impact cartilage, causing a risk of tendon ruptures. The study questions the drug makers’ failure to identify this potential concern related to the effect of these drugs on the connective tissue and negligence in studying the potential adverse events of Levaquin and Cipron on the eyes. Some of the symptoms of retinal detachment about which the drug manufacturers failed to warn the users about include:

• Flashes of light
• Dramatic rise in the number of floaters
• Feeling bulky eyes or experiencing heaviness in the eye
• Central vision loss
• Dense shadow moving from peripheral to central vision

Antibiotics Side Effects

No doubt these antibiotics help restore health and save life, but inappropriate prescription and misuse of these drugs has the potential of causing adverse events, leaving some patients with severe and permanent vision problems. Often prescribed for bronchitis, sinusitis, earaches, among other infections that can be treated even with less potent drugs, antibiotics can have life threatening side effects, which become apparent after the patient has been cured of the malaise, with the patients experiencing severe pain and weakness. A number of patients even complain of dryness in the eyes, skin, and mouth; uncontrollable shaking; ringing in ears; burning pain and sensation in eyes and feet; delayed urination; tingling in the feet and hands; muscle spasms in back; and heart palpitations. The drugs have the potential of causing severe harm to:

Read more: Antibiotics Side Effects Lawsuit

Risperdal Lawsuit Breast Side Effects

Risperdal Lawsuit Breast Side Effects

Drug maker Johnson & Johnson (JNJ) has settled a Risperdal lawsuit on the first day of trial over Risperdal side effects.

The Risperdal lawsuit filed plaintiff Aron Banks states that the Johnson & Johnson antipsychotic drug Risperdal caused him to grow breast tissue.

Aron Banks, 21, claimed he sustained psychological trauma from growing breasts after taking the medication during childhood. Banks took the medicine from 2000 to 2004, when it wasn’t approved for children.

The Banks suit in state court in Philadelphia was the first to go to trial on claims that Risperdal caused boys to grow breasts. Another trial is set to begin Sept. 20 in Philadelphia. The terms of the settlement are confidential, Steve Sheller, the plaintiff’s attorney, said following the announcement in court today.

“The case resolved and the client is satisfied,” Sheller said in an interview.

The Food and Drug Administration approved Risperdal in 1993 for psychotic disorders including schizophrenia.

Read more: Risperdal Lawsuit Breast Side Effects